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Abstract
Understanding tumor invasion and metastasis is of crucial importance for both fundamental cancer re-
search and clinical practice. In vitro experiments have established that the invasive growth of malignant
tumors is characterized by the dendritic invasive branches composed of chains of tumor cells emanating
from the primary tumor mass. The preponderance of previous tumor simulations focused on non-invasive
(or proliferative) growth. The formation of the invasive cell chains and their interactions with the pri-
mary tumor mass and host microenvironment are not well understood. Here, we present a novel cellular
automaton (CA) model that enables one to efficiently simulate invasive tumor growth in a heterogeneous
host microenvironment. By taking into account a variety of microscopic-scale tumor-host interactions,
including the short-range mechanical interactions between tumor cells and tumor stroma, degradation
of extracellular matrix by the invasive cells and oxygen/nutrient gradient driven cell motions, our CA
model predicts a rich spectrum of growth dynamics and emergent behaviors of invasive tumors. Besides
robustly reproducing the salient features of dendritic invasive growth, such as least resistance and intra-
branch homotype attraction, we also predict nontrivial coupling of the growth dynamics of the primary
tumor mass and the invasive cells. In addition, we show that the properties of the host microenvironment
can significantly affect tumor morphology and growth dynamics, emphasizing the importance of under-
standing the tumor-host interaction. The capability of our CA model suggests that well-developed in
silico tools could eventually be utilized in clinical situations to predict neoplastic progression and propose
individualized optimal treatment strategies.
2Author Summary
The goal of the present work is to develop an efficient single-cell based cellular automaton (CA) model
that enables one to investigate the growth dynamics and morphology of invasive solid tumors. Recent
experiments have shown that highly malignant tumors develop dendritic branches composed of tumor
cells that follow each other, which massively invade into the host microenvironment and ultimately lead to
cancer metastasis. Previous theoretical/computational cancer modeling neither addressed the question of
how such chain-like invasive branches form nor how they interact with the host microenvironment and the
primary tumor. Our CA model, which incorporates a variety of microscopic-scale tumor-host interactions
(e.g., the mechanical interactions between tumor cells and tumor stroma, degradation of extracellular
matrix by the tumor cells and oxygen/nutrient gradient driven cell motions), can robustly reproduce
experimentally observed invasive tumor evolution and predict a wide spectrum of invasive tumor growth
dynamics and emergent behaviors in various different heterogeneous environments. Further refinement of
our CA model could eventually lead to the development of a powerful simulation tool that can be utilized
in the clinic to predict neoplastic progression and propose individualized optimal treatment strategies.
Introduction
Cancer is not a single disease, but rather a highly complex and heterogeneous set of diseases that can adapt
in an opportunistic manner, even under a variety of stresses. It is now well accepted that genome level
changes in cells, resulting in the gain of function of oncoproteins or the loss of function of tumor suppressor
proteins, initiate the transformation of normal cells into malignant ones and neoplastic progression [1,2].
In the most aggressive form, malignant cells can leave the primary tumor, invade into surrounding tissues,
find their way into the circulatory system (through vascular network) and be deposited at certain organs
in the body, leading to the development of secondary tumors (i.e., metastases) [3].
The emergence of invasive behavior in cancer is fatal. For example, the malignant cells that invade into
the surrounding host tissues can quickly adapt to various environmental stresses and develop resistance
to therapies. The invasive cells that are left behind after resection are responsible for tumor recurrence
and thus an ultimately fatal outcome. Therefore, significant effort has been expended to understand the
mechanisms evolved in the invasive growth of malignant tumors [2, 4–7] and their treatment [8, 9]. It
is generally accepted that the invasive behavior of cancer is the outcome of many complex interactions
3occurring between the tumor cells, and between a tumor and the host microenvironment [3]. Tumor inva-
sion itself is a complex multistep process involving homotype detachment, enzymatic matrix degradation,
integrin-mediated heterotype adhesion, as well as active, directed and random motility [4]. In recent in
vitro experiments involving glioblastoma multiforme (GBM), the most malignant brain cancer, it has
been observed that dendritic invading branches composed of chains of tumor cells are emanating from
the primary tumor mass; see Fig. 1. Such invasive behaviors are characterized by intrabranch homotype
attraction and least resistance [4].
Although recently progress has been made in understanding certain aspects of the complex tumor-
host interactions that may be responsible for invasive cancer behaviors [4, 10–12], many mechanisms are
either not fully understood or are unknown at the moment. Even if all of the mechanisms for cancer
invasion could be identified, it is still not clear that progress in understanding neoplastic progression
and proposing individualized optimal treatment strategies could be made without the knowledge of how
these different mechanisms couple to one another and to the heterogeneous host microenvironment in
which tumor grows [13]. Theoretical/computational cancer modeling that integrates apart mechanisms,
when appropriately linked with experimental and clinical data, offers a promising avenue for a better
understanding of tumor growth, invasion and metastasis. A successful model would enable one to broaden
the conclusions drawn from existing medical data, suggest new experiments, test hypotheses, predict
behavior in experimentally unobservable situations, and be employed for early detection and prognosis.
Indeed, cancer modeling has been a very active area of research for the last two decades (see Refs. [14]
and [13] for recent reviews). A variety of interactions between tumor cells and between tumor and its host
microenvironment have been investigated [15–27,29–32], via continuum [25–28,32], discrete [16,20,33] or
hybrid [19, 21–23] mathematical models. Very recently, multiscale mathematical models [22, 23, 28] have
been employed to study the effects of the host microenvironment on the morphology and phenotypic evo-
lution of invasive tumors and it has been shown that microenvironmental heterogeneity can dramatically
affect the growth dynamics of invasive tumors. Although the simulated tumors showed certain invasive
characteristics (e.g., developing protruding surfaces), no dendritic invasive branches emerged.
In response to the challenge to develop an “Ising” model for cancer growth [13], we generalize a
cell-based discrete cellular automaton (CA) model that we have developed [16–18, 20, 21] to investigate
the invasive growth of malignant tumors in heterogeneous host microenvironments. To the best of our
knowledge, this generalized CA model is the first to investigate the formation of invasive cell chains and
4their interactions with the primary tumor mass and the host microenvironment. Our cellular automaton
model takes into account a variety of microscopic-scale tumor-host interactions, including the short-range
mechanical interactions between tumor cells and tumor stroma, the degradation of extracellular matrix
by the invasive cells and oxygen/nutrient gradient driven cell motions and thus, it can predict a wide
range of growth dynamics and emergent behaviors of invasive tumors. In particular, our CA model
robustly reproduces the salient features of dendritic invasive growth observed in experiments, which is
characterized by least resistance and intrabranch homotype attraction. The model also predicts nontrivial
coupling of the growth dynamics of the primary tumor mass and the invasive cells, e.g., the invasive cells
can facilitate the growth of primary tumor in harsh microenvironment. Moreover, we show that the
properties of the host microenvironment can significantly affect tumor growth dynamics and lead to a
variety of tumor morphology. These emergent behaviors naturally arise due to various microscopic-scale
tumor-host interactions, which emphasizes the importance of taking into account microenvironmental
heterogeneity in understanding cancer. Further refinement of our model could eventually lead to the
development of a powerful in silico tool that can be utilized in the clinic. As a demonstration of the
capability and versatility of our CA model, we mainly consider invasive tumor growth in two dimensions,
although the model is easily extended to three dimensions. Indeed, the algorithmic details of the model
are given for any spatial dimension.
Materials and Methods
Biophysical Background of the CA Model
Voronoi Tessellation: The Underlying Cellular Structure
The underlying cellular structure is modeled using a Voronoi tessellation of the space into polyhedra [34],
based on centers of spheres in a packing generated by a random sequential addition (RSA) process [16,21]
(see Fig. 2). In particular, nonoverlapping spheres are randomly and sequentially placed in a prescribed
region until there is no void space for additional spheres, i.e., saturation is achieved. Such a saturated
RSA packing possesses relative small variations in its Voronoi polyhedra and thus, has served as models
for many biological systems [35,36]. We refer to the polyhedra associated with the Voronoi tessellation as
automaton cells. These automaton cells may correspond to real cells or tumor stroma (e.g., clusters of the
5ECM macromolecules). In previous studies, such automaton cells have represented clusters of real cells of
various sizes or have implicitly represented healthy tissues [16]. Thus, the Voronoi tessellation associated
with RSA sphere centers provides a highly flexible model for real-cell aggregates with a high degree of
shape isotropy. For example, one can use a variable automaton cell size to simulate avascular tumor
growth from a few malignant cells to its macroscopic size [16]. In addition, such a Voronoi tessellation
can reduce the undesired growth bias due to the anisotropy of ordered tessellations based on square and
simple cubic lattices.
Since our new CA model explicitly takes into account the interactions between a single cell and its
neighbors and microenvironment, each automaton cell here represents either a single tumor cell or a
region of tumor stroma. Thus, the linear size of a single automaton cell is approximately 15− 20 µm and
the linear size of the 2D simulation domain is approximately 5 mm, which contains ∼ 100 000 automaton
cells. In the current model, we mainly focus on the effects of ECM macromolecule density and ECM
degradation by malignant cells on tumor growth. Henceforth, we will refer to the host microenvironment
(or tumor stroma) as “ECM” for simplicity. Each ECM associated automaton cell is assigned a particular
density ρECM, representing the density of the ECM molecules within the automaton cell. A tumor cell
can occupy an ECM associated automaton cell only if the density of this automaton cell ρECM = 0, which
means that either the ECM is degraded or it is deformed (pushed away) by the proliferating tumor cells.
Microenvironment Heterogeneity
The microenvironment in which tumor grows is usually highly heterogeneous, composed of various types
of stromal cells and ECM structures. The ECM is a complex mixture of macromolecules that provide
mechanical supports for the tissue (such as collagens) and those that play an important role for cell adhe-
sion and motility (such as laminin and fibronectin) [22,37,38]. For different individuals with tumors, the
ECM in the host microenvironments generally possess distinct mechanical and transport properties. By
explicitly representing the ECM using automaton cells with different macromolecule densities, the effects
of microenvironment heterogeneity on tumor growth can be very well explored. For example, various
distributions of the ECM densities (i.e., the densities of the ECM macromolecules) can be employed to
mimic the actual heterogeneous host microenvironment of the tumor. Certain tumor stroma contains
fibroblasts, which actively produce ECM macromolecules leading to a higher ECM density around these
cells. The automaton cells representing the ECM with larger densities are considered to be more rigid
6and more difficult to degrade. Since each automaton cell associated with the ECM has its own density,
this allows a variation of ECM characteristics on the length scale comparable to that of a single tumor
cell.
In addition, the tumor in our model is only allowed to grow in a compact growth-permitting region.
This is to mimic the physical confinement of the host microenvironment, such as the boundary of an
organ. In other words, only automaton cells within this region can be occupied by the cells of the tumor
as it grows. In general, the growth-permitting region can be of any shape that best models the organ
shape. Here we simply choose a spherical region to study the effects of the heterogeneous ECM on
tumor growth. More sophisticated growth-region shapes have been employed to investigate the effects of
physical confinement on tumor growth [20, 21]. Furthermore, we assume a constant radially symmetric
nutrient/oxygen gradient in the growth-permitting region with the highest nutrition concentration at the
boundary of this region, i.e., it is a vascular boundary. However, this assumption can also be relaxed.
Tumor Cell Phenotypes and Interactions with the Host Microenvironment
For highly malignant tumors, we consider the cells to be of one of the two classes of phenotypes: either
invasive or non-invasive. Following Ref. [16], the non-invasive cells remain in the primary tumor and can
be proliferative, quiescent or necrotic, depending on the nutrition supply they get. For avascular tumor
growth, as we focus here, the nutrition the tumor cells can get are essentially those diffuse into the tumor
through its surface. As the tumor grows, the amount of nutrition supply, which is proportional to the
surface area of the tumor, cannot meet the needs of all cells whose number increases with the tumor
volume, leading to the development of necrotic and quiescent regions. Following Ref. [16], characteristic
diffusion lengths are employed to determine the states of a non-invasive cell. For example, quiescent
cells more than δn away from the tumor surface become necrotic (see details in the next section). The
diffusion length δn (also the characteristic thickness of the rim of living tumor cells) depends on the size
of the primary tumor.
As a proliferative cell divides, its daughter cell effectively pushes away/degrades the surrounding ECM
and occupies the automaton cell originally associated with the ECM [39–41]. It is easier for a tumor cell
to take up an ECM associated automaton cell with lower density (i.e., less rigid ECM regions) than that
with higher density (i.e., more rigid ECM regions) and thus, the tumor growth is affected by the ECM
heterogeneity through the local mechanical interaction between tumor cells and the ECM. If there is no
7space available for the placement of a daughter cell within a distance δp from the proliferative cell, the
proliferative cell turns quiescent.
The invasive cells are considered to be mutant daughters of the proliferative cells [42], which can gain
a variety of degrees of ECM degradation ability χ (i.e., the matrix-degradative enzymes) and motility
µ that allow them to leave the primary tumor and invade into surrounding microenvironment [43]. We
consider the invasive cells can move from one automaton cell to another only if the ECM in the target
automaton cell is completely degraded (i.e., with ρECM = 0). Each trial move of an invasive cell involves
the degradation of the ECM in its neighbor automaton cells, followed by a possible move to one of the
automaton cells whose ECM is completely degraded; otherwise the invasive cell does not move. The
number of trial moves of an invasive cell and to what extent it degrades the ECM are respectively
determined by µ and χ (see the following section for details). The oxygen/nutrient gradient also drives
the invasive cells to move as far as possible from the primary tumor [44], which takes up the majority of
oxygen/nutrients. The motility µ is the maximum possible number of such trial moves. In addition, we
assume that the invasive cells do not divide as they migrate.
Algorithmic Details
We now provide specific details for the CA model to study invasive tumor growth in confined hetero-
geneous microenvironment. In what follows, we will simply refer to the primary tumor as “the tumor”
and explicitly use “invasive” when considering invasive cells. After generating the automaton cells by
Voronoi tessellation of RSA sphere centers, an ECM macromolecule density ρECM ∈ (0, 1) is assigned
to each automaton cell within the growth-permitting region, which represents the heterogeneous host
microenvironment. Then a tumor is introduced by designating any one or more of the automaton cells
as proliferative cancer cells. Time is then discretized into units that represent one real day. At each time
step:
• Each automaton cell is checked for type: invasive, proliferative, quiescent, necrotic or ECM associ-
ated. Invasive cells degrade and migrate into the ECM surrounding the tumor. Proliferative cells
are actively dividing cancer cells, quiescent cancer cells are those that are alive, but do not have
enough oxygen and nutrients to support cellular division and necrotic cells are dead cancer cells.
• All ECM associated automaton cells and tumorous necrotic cells are inert (i.e., they do not change
8type).
• Quiescent cells more than a certain distance δn from the tumor’s edge are turned necrotic. The
tumor’s edge, which is assumed to be the source of oxygen and nutrients, consists of all ECM
associated automaton cells that border the neoplasm. The critical distance δn for quiescent cells to
turn necrotic is computed as follows:
δn = aL
(d−1)/d
t ,
where a is prescribed parameter (see Table 1), d is the spatial dimension and Lt is the distance
between the geometric centroid xc of the tumor and the tumor edge cell that is closest to the
quiescent cell under consideration. The position of the tumor centroid xc is given by
xc =
x1 + x2 + · · ·+ xN
N
,
where N is the total number of noninvasive cells contained in the tumor, which is updated when a
new noninvasive daughter cell is added to the tumor.
• Each proliferative cell will attempt to divide with probability pdiv into the surrounding ECM (i.e.,
the automaton cells associated with the ECM) by degrading and pushing away the ECM in that
automaton cell. We consider that pdiv depends on both the physical confinement imposed by the
boundary of the growth-permitting region and the local mechanical interaction between the tumor
cells and the ECM, i.e.,
pdiv =


if any ECM associated automaton cell within
p0
2 [(1−
r
Lmax
) + (1− ρECM)] the predefined growth distance is in the growth-
permitting microenvironment
if no ECM associated automaton cell within
0 the predefined growth distance is in the growth-
permitting microenvironment
where p0 is the base probability of division (see Table 1), r is the distance of the dividing cell from
the tumor centroid, Lmax is the distance between the closest growth-permitting boundary cell in
9the direction of tumor growth and the tumor’s geometric centroid xc and ρECM is the ECM density
of the automaton cell to be taken by the new tumor cell. When a ECM associated automaton cell is
taken by a tumor cell, it density is set to be zero. The predefined growth distance (δp) is described
in a following bullet point.
• If a proliferative cell divides, it can produce a mutant daughter cell possessing an invasive phenotype
with a prescribed probability γ (i.e., the mutation rate). The invasive daughter cell gains ECM
degradation ability χ and motility µ, which enables it to leave the tumor and invade into surrounding
ECM. The rules for updating invasive cells are given in a following bullet point. If the daughter
cell is noninvasive, it is designated as a new proliferative cell.
• A proliferative cell turns quiescent if there is no space available for the placement of a daughter cell
within a distance δp from the proliferative cell, which is given by
δp = bL
(d−1)/d
t ,
where b a nutritional parameter (see Table 1), d is the spatial dimension and Lt is the distance
between the geometric tumor centroid xc and the tumor edge cell that is closest to the proliferative
cell under consideration.
• An invasive cell degrades the surrounding ECM (i.e., those in the neighboring automaton cells
of the invasive cell) and can move from one automaton cell to another if the associated ECM is
completely degraded. For an invasive cell with motility µ and ECM degradation ability χ, it will
make m attempts to degrade the ECM in the neighboring automaton cells and jump to these
automaton cells, where m is an arbitrary integer in [0, µ]. For each attempt, the surrounding
ECM density ρECM is decreased by δρ, where δρ is an arbitrary number in [0, χ]. Using random
numbers for ECM degradation ability and cellular motility is to take into account tumor genome
heterogeneity, which is manifested as heterogeneous phenotypes (such as differentm and δρ). When
the ECM in multiple neighboring automaton cells of the invasive cell are completely degraded (i.e.,
ρECM = 0), the invasive cell moves in a direction that maximizes the nutrients and oxygen supply.
Here we assume that the migrating invasive cells do not divide. The degraded ECM shows the
invasive path of the tumor.
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The aforementioned automaton rules are briefly illustrated in Fig. 3. We note that non-invasive tumor
growth can be studied by imposing a mutation rate γ = 0. This enables us to compare the growth
dynamics of invasive and non-invasive tumors and in turn to investigate the effects of coupling growth of
the primary tumor mass and the invasive cells. Although we only consider spherical-growth-permitting
regions here, the CA rules given above allow growth-permitting regions with arbitrary shapes. The
important parameters mentioned in the bullet points above are summarized in Table 1. In the following,
we will employ our CA model to investigate the growth dynamics of malignant tumors with different
degrees of invasiveness in variety of different heterogeneous microenvironments.
Quantitative Metrics for Tumor Morphology
To characterize quantitatively the morphology of simulated tumors, we present several scalar metrics that
capture the salient geometric features of the primary tumor, dendritic invasive branches or the entire
invasive pattern. These metrics include the ratio β of invasive area over tumor area (defined below),
the specific surface s of the invasive pattern, the asphericity α of the primary tumor and the angular
anisotropy metric ψ for the invasive branches. The metrics are computed for all simulated tumors and
compared to available experimental data. We note that the invasive pattern associated with a neoplasm
includes both the primary tumor and the invasive branches.
Following Ref. [4], the tumor area AT is defined as the area of the circumcircle of the primary tumor
(see Fig. 4(a)) and the invasive area AI is the area of the region between the effective circumcircle of the
invasive pattern and the circumcircle of the primary tumor (see Fig. 4(a)). The radius of the effective
circumcircle of the invasive pattern is defined to be the average distance from the invasive branch tip to
the tumor center. The ratio β = AI/AT as a function of time t reflects the degree of coupling between
the primary tumor and the invasive cells. If β(t) is linear in t, there is no coupling; otherwise the two
are coupled.
The specific surface s [34] for the invasive pattern is defined as the ratio of the total length of the
perimeter of the invasive pattern over its total area. In general, s is inversely proportional to the size
of the tumor and thus, large tumors have small s values. Moreover, given the tumor size, tumors with
a large number of long dendritic invasive branches possess a large value of s. And s is minimized for
perfectly circular tumors with s = 2/RT , where RT is the radius. Since s depends on the size of the
tumor, which makes it difficult to compare tumors with different sizes, in the calculations that follow
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we employ a normalized s with respect to 2/RT for an arbitrary-shaped tumor with effective radius RT
(i.e., the average distance from tumor edge to tumor center). For simplicity, we will still refer to the
normalized specific surface as “specific surface” and designate it with symbol s.
The asphericity α of the primary tumor is defined as the ratio of the radius of circumcircle Rc of the
primary tumor over its incircle radius Rin [45], i.e., α = Rc/Rin (see Fig. 4(b)). A large α value indicates
a large deviation of the shape of primary tumor from that of a perfect circle, i.e., the tumor is more
anisotropic.
To quantify the degree of anisotropy of the invasive branches, we introduce the angular anisotropy
metric ψ. In particular, the entire invasive pattern is evenly divided into na sectors with lines emanating
from the tumor center (see Fig. 4(c)). The angular anisotropy metric ψ is defined as
ψ =
∑na
i=1 |ℓ(i)− ℓave|
na · ℓave
, (1)
where ℓ(i) is the average length of the invasive branches within the ith sector and
ℓave =
∑na
i=1 ℓ(i)
na
, (2)
is the average length of all invasive branches. For tumors with invasive branches of similar lengths that
are uniformly angularly distributed, the metric ψ is small. Large fluctuations of both invasive branch
length and angular distribution can lead to large ψ values. In the following, we use na = 16 to compute
ψ for the simulated invasive tumors.
Results
Model Validation
To verify the robustness and predictive capacity of our CA model, we first employ it to quantitatively
reproduce the observed invasive growth of a GBM multicellular tumor spheroid (MTS) in vitro [4].
In particular, the boundary of the growth-permitting region is considered to be vascularized, i.e., a
growing tumor can receive oxygen and nutrients from the growth-permitting region. A constant radially
symmetric nutrient/oxygen gradient in the growth-permitting region with the highest nutrient/oxygen
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concentration at the vascular boundary is used. Initially, approximately 250 proliferative tumor cells are
introduced at the center of the growth-permitting region with homogeneous ECM and tumor growth is
started. This corresponds to an initial MTS with diameter DMTS ≈ 310 µm which is consistent with
the in vitro experiment set-up [4]. The following values of the growth and invasiveness parameters are
used: p0 = 0.384, a = 0.58 mm
1/2, b = 0.30 mm1/2, γ = 0.05, χ = 0.55, µ = 3. Note that the value of
p0 corresponds to a cell doubling time of 40 hours, which is consistent with the reported experimental
data [4]. A small value of ECM density ρECM = 0.15 is used, which corresponds to the soft DMEM
medium used in the experiment [4]. In the visualizations of the tumor that follow, we use the following
convention: the ECM in the growth-permitting region is white, and gray outside this region. The ECM
degraded by the tumor cells is blue. In the primary tumor, necrotic cells are black, quiescent cells are
yellow and proliferative cells are red. The invasive tumor cells are green.
Figure 5(a) and (b) respectively show the morphology of simulated MTS and a magnification of its
invasive branches with increasing branch width towards the proliferative core. Specifically, one can clearly
see that within the branches, chains of cells are formed as observed in experiments [4] (see Fig. 1). The
invasive cells tend to follow one another (which is termed “homotype attraction”) since paths of degraded
ECM are formed by pioneering invasive cells and it is easier for other cells to follow and enhance such
paths than degrading ECM to create new paths by themselves. In other words, invasive cells tend to take
paths with “least resistance”. We note that no CA rules are imposed to force such cellular behaviors.
Instead, they are emergent properties that arise from our simulations.
The ratio of invasion area over primary tumor area β = AI/AT as a function of time for the simulated
tumor is computed and compared to reported experimental data [4] (see Fig. 5(c)). One can clearly see
that our simulation results agree with experimental data very well. Moreover, the deviation of β(t) from
a linear function of t indicates that the growth of primary tumor and the invasive branches are strongly
coupled [4] Other metrics for tumor morphology such as the specific surface s of the invasive pattern,
the sphericity α of the primary tumor and the angular anisotropy metric ψ for the invasive branches are
computed from our simulation results and from the image of invasive MTS in Fig. 1(a) at 24 hours after
initialization. The values are given in Table 2, from which one can see again a good agreement. Thus,
we have shown that our CA model is both robust and quantitatively accurate with properly selected
parameters.
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Simulated Invasive Growth in Heterogeneous Miroenvironments
Having verified the robustness and predictive capacity of our CA model, we now consider three types of
ECM density distributions, i.e., homogeneous, random and sine-like, to systematically study the effects of
microenvironment heterogeneity on invasive tumor growth (see Fig. 6). These ECM density distributions
represent real host microenvironments in which a tumor grows. (Details about these ECM distributions
are given in the following sections.) Again, the boundary of the growth-permitting region is considered
to be vascularized with a constant radially symmetric nutrient/oxygen gradient in the growth-permitting
region pointing to the tumor center. We note that although generally the nutrient/oxygen concentration
field in vivo is more complicated, previously numerical studies that considered the exact evolution of
nutrient/oxygen concentrations have shown a decay of the concentrations toward the tumor center [22,23].
Since the directions of cell motions are determined only by the nutrient/oxygen gradient, our constant-
gradient approximation is a very reasonable one.
In the beginning, a proliferative tumor cell is introduced at the center of the growth-permitting region
and tumor growth is initiated. The growth parameters for the primary tumors in all cases studied here
are the same and are given in Table 1. The invasiveness parameters and ECM densities are variable and
specified in each case separately. The values of the growth parameters for the CA model were chosen
to be consistent with GBM data from the medical literature [16, 20]. Specifically, the value of the base
probability of division is p0 = 0.192, which corresponds to a cell doubling time of 4 days [46, 47]. This
value is used for all of the cases of invasive growth that follow. Since our CA model takes into account
general microscopic tumor-host interactions, we expect that the general growth dynamics and emergent
behaviors predicted by the model will qualitatively apply to other solid tumors. We note that all of the
reported growth dynamics and emergent properties of the simulated tumors for any specific set of growth
and invasiveness parameters are repeatedly observed in 25 independent simulations.
Effects of Cellular Motility
We first simulate the growth of malignant tumors with different degrees of invasiveness in a homogeneous
ECM with ρECM = 0.45. In particular, we consider three invasive cases with the same mutation rate
γ = 0.05 and ECM degradation ability χ = 0.9, but different cell motility µ = 1, 2, 3. A non-invasive
growth case (i.e., γ = 0) in the same microenvironment (ρECM = 0.45) is also studied for comparison
purposes.
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Figure 7 shows the simulated growing tumors 100 days after initiation (plots showing the full growth
history of the tumors are given in the Supplementary Information). The computed metrics for tumor
morphology are given in Table 3. The primary tumors for both invasive [Figs. 7(b),(c) and (d)] and
non-invasive [Fig. 7(a)] cases develop necrotic and quiescent regions. For invasive tumors, when the cell
motility is small (i.e., µ = 1), the invasive cells do not form dendritic invasive branches but rather clump
near the outer border of the proliferative rim [see Fig. 7(b)], forming bumpy invasive concentric-like shells
with relatively small specific surface (e.g., s = 1.09 on day 100). Such invasive shells significantly enhance
the growth the primary tumor, i.e., the size of the primary tumor in Fig. 7(b) is much larger than in
Figs. 7(a), (c) and (d). A quantitative comparison of the tumor sizes is given in the Supplementary
Information.
By contrast, for larger cell motility, long dendritic invasive branches are developed as manifested by
the large specific surface (e.g., s = 7.89 on day 100 and s = 9.73 on day 120 for µ = 3). In particular, one
can clearly see that within the branches the cells tend to follow one another to form chains, as observed
in experiments [4]. We emphasize that no rules are imposed to force the cells to follow on another in our
CA model. This homotype attraction is purely due to the mechanical interaction between the invasive
cells and the ECM, i.e., once a path of invasion is established by a leading invasive cell (by degrading the
ECM), other invasive cells nearby turn to follow and enhance this path since the resistance for migration
is minimized on a existing path. Furthermore, we can see that larger cell motility (i.e., high malignancy)
leads to more invasive branches [see Figs. 7(c) and (d)] and thus, a larger specific area of the invasive
pattern.
Effects of the ECM Rigidity
It is not very surprising that isotropic tumor shapes and and invasive patterns are developed in a ho-
mogeneous ECM with relative low density (i.e.,the ECM is soft) compared to the ECM degradation
ability of the invasive tumor cells. However, real tumors are rarely isotropic, primarily due to the host
microenvironment in which they grow, which we now explore.
Consider the invasive growth of a tumor in a much more rigid ECM than that in the previous section,
i.e., ρECM = 0.85. The invasiveness parameters used are γ = 0.05, µ = 3 and χ = 0.9. The snap shots
of the growing tumor are shown in Fig. 8 and the tumor morphology metrics are given in Table 3. It
can be clearly seen that both the size of the primary tumor and the extent of its invasive branches are
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much smaller than those of the tumors growing in a softer ECM (see Fig. 7). Importantly, although the
ECM is still homogeneous, due to its high rigidity, the primary tumor develops an anisotropic shape with
protrusions in the proliferation rim caused by the invasive branches (e.g., α = 1.40 and ψ = 1.02 on day
100). Since the invasive cells have degraded the ECM either completely or partially along the invasive
branches, it is easier for the proliferative cells in the primary tumor to take these “weak spots” than to
push against the rigid ECM themselves. Again, we emphasize that we do not force the cells to behave this
way by imposing special CA rules; this behavior results purely from the mechanical interaction between
the tumor and its host and the coupling dynamics of invasive and non-invasive tumor cells.
Effects of the ECM Heterogeneity: Random Distribution of ECM Density
The real host microenvironment for tumors are far from homogeneous in general. To investigate how
heterogeneity of ECM affects the tumor growth dynamics, we use a random distribution of ECM density,
i.e., for each ECM associated automaton cell, it density ρECM is a random number uniformly chosen from
the interval [0, 1] (see Fig. 6(b)). The invasiveness parameters used are γ = 0.05, µ = 3 and χ = 0.9 and
snap shots of the growing tumor are shown in Fig. 9. The tumor morphology metrics are given in Table
4. Note that the primary tumor develops a rough surface and slightly anisotropic shape in the early
growth stages (e.g., α = 1.32 on day 50 and α = 1.34 on day 80), which reflects the ECM heterogeneity
[Figs. 9(a) and (b)]. Since the characteristic heterogeneity length scale is comparable to a single cell,
its effects are diminished (e.g., α = 1.18 on day 100 and α = 1.15 on day 120) as the tumor grows
larger and larger [Fig. 9(c) and (d)]. (In other words, on large length scales, the ECM is still effectively
homogeneous.) However, the anisotropy in the invasive pattern (i.e., the extents of invasive branches in
different directions) still persists (e.g., ψ = 0.64 on day 100) even though the primary tumors almost
resumes an isotropic shape.
Effects of the ECM Heterogeneity: Sine-like Distribution of ECM Density
To represent large-scale heterogeneities in the ECM, we use a sine-like distribution of ECM density, i.e.,
for an automaton cell with centroid (x1, x2, . . . , xd), the associated ECM density is given by
ρECM(x1, . . . , xd) =
1
2d
[sin(
2πx1
L
) + 1][sin(
2πx2
L
) + 1] · · · [sin(
2πxd
L
) + 1], (3)
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where d is the spatial dimension and L is the edge length of the d-dimensional cubic simulation box. A
two-dimensional sine-like ECM distribution is shown in Fig. 6(c). The red spots correspond to large ρECM
and high ECM rigidity; they can be considered as effective obstacles (e.g., brain ventricles) that hinder
tumor growth.
Figures 10(a),(b) and (c),(d) show the snap shots of invasive tumors growing in the aforementioned
ECM on day 80 and day 120, with invasiveness parameters γ = 0.05, µ = 1 and χ = 0.9 and γ = 0.05,
µ = 3 and χ = 0.9, respectively. The plots showing the full growth history is given in Supplementary
Information and the tumor morphology metrics are given in Table 4. We can see that in the early growth
stage, both the primary tumor and invasive pattern in the two cases are significantly affected by the
ECM heterogeneity. In particular, the tumors are highly anisotropic in shape and the invasive branches
clearly favor two orthogonal directions associated with low ECM densities (e.g., α = 1.61, ψ = 1.18 for
µ = 1 on day 80; and α = 1.67, ψ = 1.33 for µ = 3 on day 80). For the case with large cellular motility,
anisotropy effects are diminished in later growth stages (α = 1.21, ψ = 0.23 for µ = 3 on day 120).
For small cellular motility, anisotropy in both primary tumor shape and the invasive pattern persists
(α = 1.26, ψ = 0.98 for µ = 1 on day 120). Furthermore, one can see that again invasive cells with low
motility significantly facilitate the growth of the primary tumor. However, instead of forming “bumpy”
concentric-like shells as in homogeneous ECM, the invasive cells form large invasive cones, protruding
into the ECM. These invasive cones are followed by weak protrusion of the proliferative rim, leading to
bumpy surface of the primary tumor. The fact that such complex growth dynamics are only observed
for tumors growing heterogeneous ECM emphasizes the crucial importance of understanding the effects
of physical heterogeneity in cancer research.
Discussion
We have developed a novel cellular automaton (CA) model which, with just a few parameters, can
produce a rich spectrum of growth dynamics for invasive tumors in heterogeneous host microenvironment.
Besides robustly reproducing the salient features of branched invasive growth, such as least resistance
and intrabranch homotype attraction observed in in vitro experiments, our model also enables us to
systematically investigate the effects of microenvironment heterogeneity on tumor growth as well as
the coupling growth of the primary tumor and the invasive cells. In particular, we have shown that
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in homogeneous ECM with low densities (i.e., soft microenvironment), both the shape of the primary
tumor and invasive pattern are isotropic. For high cellular motility cases, the invasive cells form extended
dendritic invasive branches; while for low cellular motility cases, the invasive cells clump near the primary
tumor surface and form a bumpy concentric-like shell that facilitates the growth of the primary tumor.
Tumors growing in a highly rigid homogeneous ECM can develop anisotropic shapes, facilitated by
the invasive cells that degrade the ECM; both the tumor size and the extent of invasive branches are
much smaller. In heterogeneous ECM, both the primary tumor and invasive pattern are significantly
affected during the early growth stages, i.e., anisotropic shapes and patterns are developed to avoid high
density/rigid regions of the ECM. If the characteristic length scale of the heterogeneities is comparable to
the macroscopic tumor size, such effects can persist in later growth stages. In addition, invasive cells with
large motility can significant diminish the anisotropy effects by their ECM degradation activities. We
emphasize that we did not manipulate the behavior of cells by imposing artificial CA rules to give rise to
these complex and rich growth dynamics. Instead, these are emergent behaviors that naturally arise due
to various microscopic-scale tumor-host interactions that are incorporated into our CA model, including
the short-range mechanical interaction between tumor cells and tumor stroma, and the degradation of
extracellular matrix by the invasive cells.
Note that the growth dynamics of tumors growing in a heterogeneous microenvironment is distinctly
different than those in a homogeneous microenvironment. This emphasizes the importance of under-
standing the effects of physical heterogeneity of the host microenvironment in modeling tumor growth.
Here we just make a first attempt to take into account a simple level of host heterogeneity, i.e., by consid-
ering the ECM with variable density/rigidity. Currently, the invasion of the malignant cells into the host
microenivronment is considered to be a consequence of invasive cell phenotype gained by mutation, and
is not triggered by environmental stresses. However, the effects of environmental stresses can be easily
taken into account. For example, a CA rule can be imposed that if the division probability of a malignant
cell is significantly reduced by ECM rigidity, i.e., it is extremely difficult to push away/degrade ECM to
make room for daughter cells, the malignant cell leaves the primary tumor and invades into soft regions of
surrounding ECM. This would lead to reduced tumor invasion (i.e., development of the dendritic invasive
branches) in soft microenvironments but enhanced invasion in rigid microenvironments [48].
Moreover, the spatial-temporal evolution of more complicated and realistic nutrient/ oxygen fields can
be incorporated into our CA model. This can be achieved by solving the coupled nonlinear partial differ-
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ential equations governing the evolution of the nutrient/oxygen concentrations as was done in Refs. [19]
and [21]. Since the CA rules are given for any spatial dimension, our model is readily generalized to three
dimensions. In addition, the model can be easily modified to incorporate other host heterogeneities, such
as stromal cells, blood vessels and the shape anisotropy of the host organ [20, 21]. As currently imple-
mented, a single 2D simulation takes less than 0.5 hours on a 32-bit 1.56Gb Memory 1.44GHz dual core
Dell Workstation. We expect that a 3D simulation will take no longer than 24 hours on a supercomputer
when a proper parallel implementation is used.
Such an in silica tool not only enables one to investigate tumor growth in complex heterogeneous
microenvironment that closely represents the real host microenvironments but also allows one to infer
and even reconstruct individual host microenvironment given limited growth data of tumors (such as
shape and size at various times). Such microstructural information of the individual host would be
extremely valuable for developing individualized treatment strategies. For example, based on the host
microstructure one can design special encapsulation and transport agents that maximize drug delivery
efficiency [13].
In our current CA model, the microscopic parameters governing tumor invasion are variable and can
be arbitrarily chosen within a feasible range as given in Table 1. Given sufficient and reliable experimental
data of invasive tumor growth, the parameters in our CA model can be uniquely determined and thus,
the model can produce robust predictions on the neoplastic progression. Although the current CA model
is specifically implemented to reproduce and predict the growth dynamics of invasive solid tumors in
vitro, further refinement of the model could eventually lead to the development of a powerful simulation
tool that can be utilized clinically. For example, more complicated and realistic host heterogeneities
such as the vascular structure, various stromal cells, the corresponding spatial-temporal evolution of the
nutrient/oxygen concentrations as well as environmental stress-induced mutations should be incorporated
as we described earlier. If the robustness of the refined model could be validated clinically, we would
expect it to produce quantitative predictions for in vivo tumor growth, which are valuable for tumor
prognosis and proposing individualized treatment strategies.
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Figure Legends
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(a) (b)
Figure 1. GBM multicelluar tumor spheroid (MTS) gel assay showing dendritic invasive
branches. (a) The invasive branches centrifugal evolve from the central MTS. The linear size of central
MTS is approximately 400 µm. (b) The invasive branches are composed of chains of invasive cells. The
images are adapted from Ref. [4].
(a) (b)
Figure 2. A 2D Voronoi tessellation and the associated point configuration. (a) A Voronoi
tessellation of the 2D plane into polygons which are the automaton cells in our model. (b) The
associated point configuration for the tessellation, generated by randomly placing nonoverlap circular
disks in a prescribed region, i.e., the random sequential addition process [34].
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(a) (b) (c) (d)
Figure 3. Illustration of cellular automaton rules. Necrotic cells are black, quiescent cells are
yellow, proliferative cells are red and invasive tumor cells are green. The ECM associated automaton
cells are white and the degraded ECM is blue. (a) A proliferative cell (dark red) is too far away from
the tumor edge to get sufficient nutrients/oxygen and it will turn quiescent in panel (b). A quiescent
cell (dark yellow) is too far away from the tumor edge and it will turn necrotic in panel (b). Another
proliferative cell (light red) will produce a daughter proliferative cell in panel (b). (b) The dark red
proliferative cell and the dark yellow quiescent cell in panel (a) turned quiescent and necrotic,
respectively. The light red proliferative cell in panel (a) produced a daughter cell. Another proliferative
cell (light red) will produce a mutant invasive daughter cell. (c) The light red proliferative cell in (b)
produced an invasive cell. (d) The invasive cell degraded the surrounding ECM and moved to another
automaton cell.
(a) (b) (c)
Figure 4. Schematic illustration of the quantities in the definitions of tumor morphology
metrics. (a) Invasive area AI and tumor area AT associated with the invasive pattern. (b)
Circumcircle with radius Rc and incircle with radius Rin associated with the primary tumor. (c) Evenly
dividing the invasive pattern into na = 8 sectors for computing angular anisotropy metric ψ.
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Figure 5. Simulated invasive growth of MTS in vitro. (a) A snapshot of the simulated growing
MTS at 24 hours after initialization. The region circled is magnified in panel (b). (b) A magnification
of the circled region in panel (a). One can clearly see that the invasive cells (green) are following each
other to form chains within the dendritic branches (blue), as observed in experiment [4]. (c)
Comparison of β = AI/AT as a function of time associated with the simulated MTS and the in vitro
experimental data [4].
(a) (b) (c)
Figure 6. Different distributions of ECM densities. (a) Uniform distribution. (b) Random
distribution, i.e., the value of ρECM is completely independent of ρECM values of other automaton cells.
(c) Sine-like distribution defined by Eq. (3) to mimic the obstacles for a growing tumor.
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(a) µ = 0 (b) µ = 1 (c) µ = 2 (d) µ = 3
Figure 7. Simulated growing tumors in homogeneous ECM with ρECM = 0.45 on day 100
after initiation. For the invasive growth, the mutation rate is γ = 0.05 and ECM degradation ability
is χ = 0.9, (a) Tumor cells are noninvasive, i.e., γ = 0. (b) Invasive tumor with cellular motility µ = 1.
(c) Invasive tumor with cellular motility µ = 2. (d) Invasive tumor with cellular motility µ = 3. Note
that the size of the primary tumor whose growth is facilitated by the concentric-like shell formed by
clumpped invasive cells (b) is much larger than the other cases. Invasive cells with a larger motility lead
to more dendritic invasive branches.
(a) (b) (c) (d)
Figure 8. Evolution of simulated tumor in homogeneous ECM with ρECM = 0.85. The
mutation rate is γ = 0.05, the cell motility is µ = 3 and ECM degradation ability is χ = 0.9. (a)
Growing tumor on day 50. (b) Growing tumor on day 80. (c) Growing tumor on day 100. (d) Growing
tumor on day 120. Note that although the ECM is homogeneous, due to its high rigidity, the primary
tumor develops an anisotropic shape with protrusions in the proliferation rim caused by the invasive
branches. Also note that the invasive cells clump at the tips of certain invasive branches due to the high
ECM rigidity.
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(a) (b) (c) (d)
Figure 9. Evolution of simulated tumor in random ECM. The mutation rate is γ = 0.05, the cell
motility is µ = 3 and ECM degradation ability is χ = 0.9. (a) Growing tumor on day 50. (b) Growing
tumor on day 80. (c) Growing tumor on day 100. (d) Growing tumor on day 120. Note that both the
primary tumor and invasive pattern are affected (i.e., becoming anisotropic) by the ECM heterogeniety
in the early growth stages. Also note that unlike the case in Fig.6(d), the invasive cells clump at the
tips of invasive branches since they have reached the boundary of the growth-permitting region.
(a) µ = 1 (b) µ = 1 (c) µ = 3 (d) µ = 3
Figure 10. Simulated growing tumors in sine-like ECM with different motilities (µ = 1, 3).
The mutation rate is γ = 0.05 and ECM degradation ability is χ = 0.9. (a) Growing tumor with cell
motility µ = 1 on day 80. (b) Growing tumor with cell motility µ = 1 on day 120. (c) Growing tumor
with cell motility µ = 3 on day 80. (d) Growing tumor with cell motility µ = 3 on day 120. Note that
both the primary tumor and invasive pattern in the two cases are significantly affected by the ECM
heterogeneity, i.e., the tumors are highly anisotropic in shape and the invasive branches clearly favor
two orthogonal directions associated with low ECM densities in the early growth stages.
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Table 1. Parameters and terms in the CA model
Time dependent terms
Lt Local tumor radius (varies with cell positions)
Lmax Local maximum tumor extent (varies with cell positions)
δp Characteristic proliferative rim thickness
δn Characteristic living-cell rim thickness (determines necrotic fraction)
pdiv Probability of division (varies with cell positions)
Growth parameters
p0 Base probability of division, linked to cell-doubling time (0.192 and 0.384)
a Base necrotic thickness, controlled by nutritional needs (0.58 mm1/2)
b Base proliferative thickness, controlled by nutritional needs (0.30 mm1/2)
Invasiveness parameters
γ Mutation rate (determines the number of invasive cells, 0.05)
χ ECM degradation ability (0.4− 1.0)
µ Cell motility (the number of “jumps” from one automaton cell to another, 1− 3)
Other terms
ρECM ECM density (determines the ECM rigidity and varies with positions, 0.0− 1.0)
Summarized here are definitions of the parameters for tumor growth and invasion, and all other
(time-dependent) quantities used in the simulations. For each parameter, the number(s) listed in
parentheses indicates the value or range of values assigned to the parameters during the simulations.
The values of the parameters are chosen such that the CA model can reproduce reported growth
dynamics of GBM from the medical literature [4, 16, 20].
Table 2. Comparison of tumor morphology metrics associated with simulated MTS and
experimental data at 24 hours after tumor initialization.
Metrics Simulated MTS Experimental data
Specific surface s 9.24 9.78
Asphericity α 1.09 1.12
Angular anisotropy metric ψ 0.17 0.19
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Table 3. Morphology metrics for simulated tumors growing in homogeneous ECM.
Noninvasive tumor in ECM with ρECM = 0.45
Metrics Day 50 Day 80 Day 100 Day 120
Specific surface s 1.23 1.13 1.09 1.04
Asphericity α 1.21 1.18 1.08 1.12
Invasive tumor with µ = 1 in ECM with ρECM = 0.45
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 0.66 0.38 0.21 0.19
Specific surface s 1.76 1.48 1.26 1.18
Asphericity α 1.23 1.12 1.08 1.06
Angular anisotropy metric ψ 0.13 0.29 0.33 0.17
Invasive tumor with µ = 2 in ECM with ρECM = 0.45
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 1.28 2.12 2.67 2.08
Specific surface s 1.94 3.92 3.67 3.28
Asphericity α 1.42 1.38 1.16 1.23
Angular anisotropy metric ψ 0.86 0.67 0.64 0.45
Invasive tumor with µ = 3 in ECM with ρECM = 0.45
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 2.14 2.43 2.64 2.89
Specific surface s 1.71 4.28 7.89 9.73
Asphericity α 1.38 1.27 1.13 1.8
Angular anisotropy metric ψ 1.25 0.68 0.41 0.18
Invasive tumor with µ = 3 in ECM with ρECM = 0.85
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT - 5.17 3.89 2.63
Specific surface s 1.21 3.40 3.91 5.79
Asphericity α 1.33 1.36 1.40 1.56
Angular anisotropy metric ψ - 1.32 1.02 0.65
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Table 4. Morphology metrics for simulated tumors growing in heterogeneous ECM.
Invasive tumor with µ = 3 in random ECM
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 2.54 4.14 2.13 2.78
Specific surface s 2.47 3.97 4.65 8.98
Asphericity α 1.32 1.34 1.18 1.15
Angular anisotropy metric ψ 0.63 0.87 0.64 0.19
Invasive tumor with µ = 1 in sine-like ECM
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 2.78 2.46 1.28 0.86
Specific surface s 1.89 2.95 2.73 1.92
Asphericity α 1.42 1.61 1.49 1.26
Angular anisotropy metric ψ 1.23 1.18 1.09 0.98
Invasive tumor with µ = 3 in sine-like ECM
Metrics Day 50 Day 80 Day 100 Day 120
β = AI/AT 5.24 3.86 3.13 2.96
Specific surface s 2.51 4.12 6.13 8.76
Asphericity α 1.19 1.67 1.48 1.21
Angular anisotropy metric ψ 1.36 1.33 0.88 0.23
